Sharon Hanegraaf
Vice President of Regulatory Affairs / Argenica Therapeutics
Rank | Company | # | |
---|---|---|---|
123rd | ![]() |
International Equities Corporation | $2.60m |
124th | ![]() |
Argenica Therapeutics | $2.60m |
125th | ![]() |
NeuroScientific Biopharmaceuticals | $2.21m |
126th | ![]() |
Sprintex | $2.17m |
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
463rd | Alchemy Resources | -14.35% | -18.12% |
464th | Ardea Resources | -14.89% | -5.08% |
465th | Argenica Therapeutics | -15% | 0% |
466th | Noble Helium | -15.1% | 0% |
467th | Kingsrose Mining | -15.3% | -0.01% |
![]() |
NEWS: Tagged in Board moves August 7, 2025 | 07 Aug 2025 |
![]() |
NEW ROLE: Vice President of Regulatory Affairs, Argenica Therapeutics | 07 Aug 2025 |
Access to our data for Sharon Hanegraaf is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sharon Hanegraaf is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.